STERIS Corporation Announces Date of Fiscal 2009 Second Quarter Earnings Release and Conference Call

Friday, October 17, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

MENTOR, Ohio, Oct. 16 STERIS Corporation (NYSE:STE) today announced that it will issue its fiscal 2009 second quarterearnings release before the market opens on October 30, 2008, followed by aconference call at 10:00 a.m. Eastern time. The conference call can be heardlive over the Internet at or via phone by dialing1-888-392-9976 in the United States and Canada, and 1-517-645-6486internationally, then referencing the password "STERIS" and the conferenceleader's name, "Julie Winter."

For those unable to listen to the conference call live, a replay will beavailable from 12:00 p.m. Eastern time on October 30, 2008 until 5:00 p.m.Eastern time on November 13, 2008, either over the Internet or via phone by calling 1-800-756-3940 in the United Statesand Canada, and 1-402-998-0796 internationally.


The mission of STERIS Corporation is to provide a healthier today andsafer tomorrow through knowledgeable people and innovative infectionprevention, decontamination and health science technologies, products andservices. The Company's more than 5,000 dedicated employees around the worldwork together to supply a broad array of solutions by offering a combinationof equipment, consumables and services to healthcare, pharmaceutical,industrial and government customers. The Company is listed on the New YorkStock Exchange under the symbol STE. For more information, .

This news release and the conference call referenced here may containstatements concerning certain trends, expectations, forecasts, estimates, orother forward-looking information affecting or relating to the Company or itsindustry that are intended to qualify for the protections afforded"forward-looking statements" under the Private Securities Litigation ReformAct of 1995 and other laws and regulations. Forward-looking statements speakonly as to the date of this report, and may be identified by the use offorward-looking terms such as "may," "will," "expects," "believes,""anticipates," "plans," "estimates," "projects," "targets," "forecasts,""confidence," and "seeks," or the negative of such terms or other variationson such terms or comparable terminology. Many important factors could causeactual results to differ materially from those in the forward-lookingstatements including, without limitation, disruption of production orsupplies, changes in market conditions, political events, pending or futureclaims or litigation, competitive factors, technology advances, and changes ingovernment regulations or the application or interpretation thereof. Otherrisk factors are described in the Company's Form 10-K and other securitiesfilings. Many of these important factors are outside STERIS's control. Noassurances can be provided as to any future financial results. Unless legallyrequired, the Company does not undertake to update or revise anyforward-looking statements even if events make clear that any projectedresults, express or implied, will not be realized. Other potential risks anduncertainties that could cause actual results to differ materially from thosein the forward-looking statements include, without limitation, (a) thepotential for increased pressure on pricing that leads to erosion of profitmargins, (b) the possibility that market demand will not develop for newtechnologies, products or applications, or the Company's business initiativeswill take longer, cost more or produce lower benefits than anticipated, (c)the possibility that application of or compliance with laws, court rulings,regulations, regulatory actions, including without limitation, the previouslydisclosed FDA warning letter, certifications or other requirements orstandards may delay or prevent new product introductions, affect theproduction and marketing of existing products, or otherwise affect Companyperformance, results, or value, (d) the potential of international unrest oreffects of fluctuations in currencies, tax assessments or rates, raw materialcosts, benefit or retirement plan costs, or other regulatory compliance costs,(e) the possibility of reduced demand, or reductions in the rate of growth indemand, for the Company's products and services, and (f) the possibility thatanticipated cost savings may not be achieved, or that transition, labor,competition, timing, execution, regulatory, governmental, or other issues orrisks associated with the matters described in the referenced conference callmay adversely impact Company performance, results, or value.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store